Mylan (MYL +0.5%) says the FDA has approved its Rizatriptan benzoate tablets - a generic version...

|About: Mylan Inc (MYL)|By:, SA News Editor

Mylan (MYL +0.5%) says the FDA has approved its Rizatriptan benzoate tablets - a generic version of Merck's (MRK) Maxalt tablets - for the treatment of migraine headaches in adults.